Track the Indivior PLC stock price and the full directors' dealings record of the company, a listed issuer based in United Kingdom. Shares are listed on the UK market, under the oversight of RNS (LSE). Market capitalisation: €4.8bn. The latest transaction was reported on 7 January 2026 (Acquisition). Among the most active insiders: Mark Crossley. Every trade is free.
85
Insider Decl.
n/a
Thresholds
€3m
36 ops.
Buy Volume
€16m
12 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Indivior PLC Strong Buy (bullish), based on 6 analysts. Average price target: US$50.83.
52Σ signal
Buys €3m€16m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,600 of 29,055 companies
60.0
score / 100
Value
41
Quality
79
FCF yld-2.0%
Earn yld4.4%
EV/EBITDA16.9x
ROE·
Gross mgn80%
Net mgn17%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,764 sharesOutside a trading venueISINISIN GB00BN4HT335RNS:5560513-0
25 of 85 declarations
Acerca de Indivior PLC
Indivior PLC es una empresa farmacéutica centrada en el tratamiento de trastornos por uso de sustancias. Cotiza en la Bolsa de Valores de Londres con el ticker INDV.